269 related articles for article (PubMed ID: 10896537)
1. [Case of pulmonary aspergillosis successfully treated with itraconazole].
Watanabe T; Kuriyama K; Kamei K
Jpn J Antibiot; 2000 Feb; 53(2):103-6; discussion 106-7. PubMed ID: 10896537
[No Abstract] [Full Text] [Related]
2. [A case of secondary invasive pulmonary aspergillosis originating from an aspergilloma, successfully treated with itraconazole].
Nakagawa Y; Shimazu K; Ebihara M; Amann K
Nihon Kokyuki Gakkai Zasshi; 1998 Mar; 36(3):294-8. PubMed ID: 9656680
[TBL] [Abstract][Full Text] [Related]
3. Disseminated invasive aspergillosis in an apparently immunocompetent host.
Raja NS; Singh NN
J Microbiol Immunol Infect; 2006 Feb; 39(1):73-7. PubMed ID: 16440127
[TBL] [Abstract][Full Text] [Related]
4. Multidrug resistance in Aspergillus fumigatus.
Warris A; Weemaes CM; Verweij PE
N Engl J Med; 2002 Dec; 347(26):2173-4. PubMed ID: 12501236
[No Abstract] [Full Text] [Related]
5. [Invasive pulmonary aspergillosis caused by Aspergillus ochraceus].
Wierzbicka M; Podsiadło B; Janczarski M
Pneumonol Alergol Pol; 1997; 65(3-4):254-60. PubMed ID: 9489424
[TBL] [Abstract][Full Text] [Related]
6. Itraconazole for the treatment of pulmonary aspergillosis in heart transplant recipients.
Nanas JN; Saroglou G; Anastasiou-Nana MI; Kostis EB; Petrochilou-Paschou VP; Kontoyannis DA; Stamatelopoulos SF; Moulopoulos SD
Clin Transplant; 1998 Feb; 12(1):30-4. PubMed ID: 9541420
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma.
Chen J; Li H; Li R; Bu D; Wan Z
J Antimicrob Chemother; 2005 Jan; 55(1):31-7. PubMed ID: 15563516
[TBL] [Abstract][Full Text] [Related]
8. Aspergillus fumigatus isolated from blood samples of a patient with pulmonary aspergilloma after embolization.
Seki M; Maesaki S; Hashiguchi K; Tomiyama Y; Tomono K; Tashiro T; Kohno S
Intern Med; 2000 Feb; 39(2):188-90. PubMed ID: 10732844
[TBL] [Abstract][Full Text] [Related]
9. [Case of polycystic lung disease with mixed infections due to Aspergillus and Mycobacterium fortuitum successfully treated by AZM].
Ito N; Kudo S
Jpn J Antibiot; 2002 Dec; 55(6):893-7. PubMed ID: 12664928
[No Abstract] [Full Text] [Related]
10. Itraconazole preexposure attenuates the efficacy of subsequent amphotericin B therapy in a murine model of acute invasive pulmonary aspergillosis.
Lewis RE; Prince RA; Chi J; Kontoyiannis DP
Antimicrob Agents Chemother; 2002 Oct; 46(10):3208-14. PubMed ID: 12234846
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of SCH51048 in an experimental model of pulmonary aspergillosis.
Allendoerfer R; Loebenberg D; Rinaldi MG; Graybill JR
Antimicrob Agents Chemother; 1995 Jun; 39(6):1345-8. PubMed ID: 7574528
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary aspergillosis in an immunocompetent patient.
Ko JP; Kim DH; Shepard JA
J Thorac Imaging; 2002 Jan; 17(1):70-3. PubMed ID: 11828215
[TBL] [Abstract][Full Text] [Related]
13. [Epidural aspergillosis secondary to lung aspergilloma despite long-term itraconazole treatment].
Jeanrot C; Guigui P; Groussard O; Deburge A
Rev Chir Orthop Reparatrice Appar Mot; 2001 Oct; 87(6):596-600. PubMed ID: 11685151
[TBL] [Abstract][Full Text] [Related]
14. [Combination therapy of micafungin and itraconazole for a case of pulmonary aspergillosis].
Maruyama T; Takagi T; Yuda H
Nihon Kokyuki Gakkai Zasshi; 2005 Feb; 43(2):94-8. PubMed ID: 15770940
[TBL] [Abstract][Full Text] [Related]
15. Itraconazole and anti-tuberculosis drugs.
Blomley M; Teare EL; de Belder A; Thway Y; Weston M
Lancet; 1990 Nov; 336(8725):1255. PubMed ID: 1978097
[No Abstract] [Full Text] [Related]
16. Tissue distribution and antifungal effect of liposomal itraconazole in experimental cryptococcosis and pulmonary aspergillosis.
Le Conte P; Joly V; Saint-Julien L; Gillardin JM; Carbon C; Yeni P
Am Rev Respir Dis; 1992 Feb; 145(2 Pt 1):424-9. PubMed ID: 1310577
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of ambruticin analogs in a murine model of invasive pulmonary aspergillosis.
Chiang LY; Ejzykowicz DE; Tian ZQ; Katz L; Filler SG
Antimicrob Agents Chemother; 2006 Oct; 50(10):3464-6. PubMed ID: 17005833
[TBL] [Abstract][Full Text] [Related]
18. Lack of efficacy of voriconazole therapy in 2 patients with pulmonary fungus balls.
Gutierrez F; Masia M; Ramos JM; Elia M; Rodriguez-Tudela JL; Cuenca-Estrella M
Clin Infect Dis; 2005 Jun; 40(11):1706-7. PubMed ID: 15889381
[No Abstract] [Full Text] [Related]
19. Chronic systemic aspergillosis.
Rüchel R; Kern W
Mycoses; 1997; 40(1-2):1. PubMed ID: 9260476
[No Abstract] [Full Text] [Related]
20. Standardization of an experimental murine model of invasive pulmonary aspergillosis.
Sheppard DC; Graybill JR; Najvar LK; Chiang LY; Doedt T; Kirkpatrick WR; Bocanegra R; Vallor AC; Patterson TF; Filler SG
Antimicrob Agents Chemother; 2006 Oct; 50(10):3501-3. PubMed ID: 17005844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
